Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2026-06-14 @ 11:03 AM
Study NCT ID:
NCT02575404
Status:
COMPLETED
Last Update Posted:
2023-06-05
First Post:
2015-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients
Sponsor:
Organization: